In precision medicine era, the pathology diagnosis is able to define the best therapy for each patient. The increasing incidence of disease, especially cancer, has been the major driver of tissue processing quality into the diagnostics workflow. The Donatello Series 2, is an innovative design and safe instrument thanks to various technical features as the SelfCheck Technology and EVA (Emergengy eVoluted Alghotithm). The design is able to perform a proper processing, confers quality into the samples and preserves morphological and molecular information, important for diagnostic purpose.

Creation, management and coordination of institutional innovation projects and scientific initiatives to support the identity of Diapath S.p.A. Management of the innovation and products development. Develop and apply innovative approaches to reagents, technology instruments, histopathology, cytopathology and molecular pathology lines. Coordinate all stages of product development, from initial concept art, to finalization and distribution. Define times of innovation projects, coordinating the work between Product Application Specialist and R&D Departments. Influence and guide the choices and plans of the R&D departments. Definition of marketing strategy, identifying market segments taken as target, positioning and formulation of the contents. Planning, management and evaluation of business communication processes Motivation Product development is not an end in itself. No wandering in dreams, but working today, to remain competitive tomorrow. Being focused and effective creates the space for creativity that matters. At the same time, manage the patent, writing draft as author, after participation in the elaboration of research and collaboration contracts for research purposes and manage the filing of trademark applications. combine their passion for the scientific and technical aspects of inventions and their knowledge of industrial property law.

DIAPATH is a private company operating independently and distributing its own products world-wide. The mission is to invest constantly in innovation to develop a complete portfolio of instruments, reagents and consumables totally dedicated to anatomic pathology. With experience in the market, Diapath successfully provide high quality products and customized services to hospitals and laboratories all around the world. Diapath invest in R&D to create innovative products that help operators work safer. In order to guarantee reliability and quality, most of products are designed, manufactured and tested directly by Diapath Innovation Department (Italy Headquarter). Diapath is ISO 9001 and 13485 certified. All processes, products and services conform to the relevant guidelines and standards. Diapath use the services of accredited certification bodies to obtain the CE, TUV, UL and other mandatory certifications specific to individual markets. Conformity with certification standards means that the quality of the products is guaranteed. Diapath helps partners with the procedures for obtaining product registration in their local markets. In Diapath works also Area Managers specific to each geographical market to ensure a greater focus and closer attention to local needs. Area Managers provide invaluable on-site support to distributors. Diapath has won the SAP (business software solutions) Fast Start Program, chosen from 350 companies for its forward-thinking innovation, sustainability and reliability policy. Through forming specialised alliances, Diapath has managed to incorporate partners in supply chain, completing the circle of technical skills and commercial competence necessary for the launching of our products.